Page last updated: 2024-11-05

tranexamic acid and Carcinoma, Lewis Lung

tranexamic acid has been researched along with Carcinoma, Lewis Lung in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baguley, BC1
Leteurtre, F1
Riou, JF1
Finlay, GJ1
Pommier, Y1

Other Studies

1 other study available for tranexamic acid and Carcinoma, Lewis Lung

ArticleYear
A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:2

    Topics: Amsacrine; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; DNA Fragmentation; DNA Topoisomera

1997